

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 7.78446026 |
| 2 | cytidine catabolic process (GO:0006216) | 7.78446026 |
| 3 | cytidine deamination (GO:0009972) | 7.78446026 |
| 4 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.91405808 |
| 5 | DNA deamination (GO:0045006) | 6.39790259 |
| 6 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 6.31955585 |
| 7 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 6.17146311 |
| 8 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.06399805 |
| 9 | regulation of regulatory T cell differentiation (GO:0045589) | 6.00516544 |
| 10 | eosinophil chemotaxis (GO:0048245) | 5.90643217 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.75785314 |
| 12 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.71679029 |
| 13 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.71679029 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.63777441 |
| 15 | positive regulation of T cell chemotaxis (GO:0010820) | 5.57050282 |
| 16 | regulation of T cell chemotaxis (GO:0010819) | 5.57050282 |
| 17 | regulation of lymphocyte chemotaxis (GO:1901623) | 5.56827549 |
| 18 | response to interleukin-15 (GO:0070672) | 5.53597411 |
| 19 | cellular response to interleukin-15 (GO:0071350) | 5.43653480 |
| 20 | monocyte chemotaxis (GO:0002548) | 5.42303840 |
| 21 | eosinophil migration (GO:0072677) | 5.33317317 |
| 22 | negative regulation of T cell apoptotic process (GO:0070233) | 5.00929742 |
| 23 | positive thymic T cell selection (GO:0045059) | 4.99686024 |
| 24 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.93293345 |
| 25 | negative regulation by host of viral transcription (GO:0043922) | 4.92359653 |
| 26 | activated T cell proliferation (GO:0050798) | 4.82824126 |
| 27 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.80735515 |
| 28 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.79815773 |
| 29 | regulation of chronic inflammatory response (GO:0002676) | 4.76737459 |
| 30 | regulation of T cell tolerance induction (GO:0002664) | 4.75045144 |
| 31 | regulation of activation of Janus kinase activity (GO:0010533) | 4.70223183 |
| 32 | macrophage chemotaxis (GO:0048246) | 4.64235990 |
| 33 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.61771857 |
| 34 | positive T cell selection (GO:0043368) | 4.56068560 |
| 35 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.51725919 |
| 36 | dendritic cell chemotaxis (GO:0002407) | 4.41394178 |
| 37 | positive regulation of tolerance induction (GO:0002645) | 4.38664574 |
| 38 | positive regulation of cell killing (GO:0031343) | 4.36189964 |
| 39 | positive regulation of lymphocyte migration (GO:2000403) | 4.31038051 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 4.23476678 |
| 41 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.17911883 |
| 42 | regulation of cell killing (GO:0031341) | 4.16994942 |
| 43 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.13629993 |
| 44 | regulation of tolerance induction (GO:0002643) | 4.12303220 |
| 45 | positive regulation of T cell apoptotic process (GO:0070234) | 4.11194245 |
| 46 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.99430347 |
| 47 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.97451559 |
| 48 | negative regulation of cell killing (GO:0031342) | 3.97451559 |
| 49 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.93318289 |
| 50 | regulation of mononuclear cell migration (GO:0071675) | 3.91663178 |
| 51 | granulocyte activation (GO:0036230) | 3.89429340 |
| 52 | negative regulation of viral genome replication (GO:0045071) | 3.81092043 |
| 53 | dendritic cell migration (GO:0036336) | 3.79209922 |
| 54 | regulation of macrophage chemotaxis (GO:0010758) | 3.71894208 |
| 55 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.71178031 |
| 56 | T cell migration (GO:0072678) | 3.69934357 |
| 57 | negative regulation of B cell proliferation (GO:0030889) | 3.68569664 |
| 58 | regulation of lymphocyte migration (GO:2000401) | 3.67121497 |
| 59 | membrane raft organization (GO:0031579) | 3.65415909 |
| 60 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.63737320 |
| 61 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.63653723 |
| 62 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.62816878 |
| 63 | regulation of T cell apoptotic process (GO:0070232) | 3.62495715 |
| 64 | interferon-gamma production (GO:0032609) | 3.59459147 |
| 65 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.59283764 |
| 66 | lymphocyte chemotaxis (GO:0048247) | 3.57085571 |
| 67 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.55594362 |
| 68 | positive regulation of T cell migration (GO:2000406) | 3.55048985 |
| 69 | T cell costimulation (GO:0031295) | 3.54804865 |
| 70 | lymphocyte costimulation (GO:0031294) | 3.49875924 |
| 71 | actin nucleation (GO:0045010) | 3.46379337 |
| 72 | T cell selection (GO:0045058) | 3.45782643 |
| 73 | thymic T cell selection (GO:0045061) | 3.44730386 |
| 74 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.42772256 |
| 75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.42309136 |
| 76 | regulation of T cell migration (GO:2000404) | 3.41148347 |
| 77 | negative regulation of interleukin-12 production (GO:0032695) | 3.40119027 |
| 78 | positive regulation of translational initiation (GO:0045948) | 3.39464427 |
| 79 | cellular defense response (GO:0006968) | 3.37945439 |
| 80 | regulation of monocyte chemotaxis (GO:0090025) | 3.36562449 |
| 81 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.35835675 |
| 82 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.35664732 |
| 83 | negative T cell selection (GO:0043383) | 3.34859732 |
| 84 | regulation of interleukin-8 secretion (GO:2000482) | 3.30406143 |
| 85 | neutrophil activation (GO:0042119) | 3.30283743 |
| 86 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.28701310 |
| 87 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.26667644 |
| 88 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.26188322 |
| 89 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.22040053 |
| 90 | positive regulation of leukocyte apoptotic process (GO:2000108) | 3.20989841 |
| 91 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.18816684 |
| 92 | negative regulation of viral transcription (GO:0032897) | 3.17288739 |
| 93 | negative regulation of B cell activation (GO:0050869) | 3.11256066 |
| 94 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.05869332 |
| 95 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.05035289 |
| 96 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.05035289 |
| 97 | negative thymic T cell selection (GO:0045060) | 2.99688745 |
| 98 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.98614677 |
| 99 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.95843208 |
| 100 | negative regulation of T cell activation (GO:0050868) | 2.94266362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 9.05108237 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.68021184 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.31628342 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.15261826 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.30016214 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.25919096 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.68375809 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.66588909 |
| 9 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.22644576 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.09886709 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.06089782 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.88249742 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.81624065 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.59999535 |
| 15 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.46072249 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.45996849 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.43875782 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.31534382 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.17812869 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.16559952 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.14217183 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.13322993 |
| 23 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99615823 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 1.99359318 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.97311246 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96688697 |
| 27 | MAF_26560356_Chip-Seq_TH2_Human | 1.94010861 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.88715073 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87635006 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76691318 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74402899 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.68885859 |
| 33 | GATA3_26560356_Chip-Seq_TH2_Human | 1.68565504 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.64714531 |
| 35 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61417132 |
| 36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.48587144 |
| 37 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.44286156 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42241134 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40182520 |
| 40 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35067949 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32000996 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31203970 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23838025 |
| 44 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.22759390 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18184403 |
| 46 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17329273 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13790228 |
| 48 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11877418 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.06565400 |
| 50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.05712814 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04812570 |
| 52 | GATA3_26560356_Chip-Seq_TH1_Human | 1.01338129 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00272910 |
| 54 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.99752522 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96208286 |
| 56 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94514097 |
| 57 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92703095 |
| 58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91822796 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87702960 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86259044 |
| 61 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85108798 |
| 62 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.85053923 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.84030571 |
| 64 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83219900 |
| 65 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.83134935 |
| 66 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82324791 |
| 67 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82257475 |
| 68 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81342472 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.78360344 |
| 70 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76677096 |
| 71 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75875888 |
| 72 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75319702 |
| 73 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.74611578 |
| 74 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74577639 |
| 75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73645991 |
| 76 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.72575137 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71750261 |
| 78 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.71405860 |
| 79 | P300_27268052_Chip-Seq_Bcells_Human | 0.71078554 |
| 80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70736464 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.70470457 |
| 82 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.69999342 |
| 83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.69602974 |
| 84 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.69262324 |
| 85 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.68820005 |
| 86 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.68702747 |
| 87 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.68597070 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68254590 |
| 89 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.67637990 |
| 90 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.67399314 |
| 91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.67047400 |
| 92 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.66942482 |
| 93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.66156095 |
| 94 | MYC_22102868_ChIP-Seq_BL_Human | 0.65702753 |
| 95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64971151 |
| 96 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64628305 |
| 97 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.63296244 |
| 98 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.62872303 |
| 99 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.62409481 |
| 100 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.60325088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.84896554 |
| 2 | MP0006082_CNS_inflammation | 4.12907308 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.55872083 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.52431199 |
| 5 | MP0009785_altered_susceptibility_to | 3.38441751 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.16666073 |
| 7 | MP0001800_abnormal_humoral_immune | 3.08804194 |
| 8 | MP0009333_abnormal_splenocyte_physiolog | 3.05283723 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.97101554 |
| 10 | MP0002723_abnormal_immune_serum | 2.89643390 |
| 11 | MP0005025_abnormal_response_to | 2.82465061 |
| 12 | MP0005387_immune_system_phenotype | 2.82123810 |
| 13 | MP0001790_abnormal_immune_system | 2.82123810 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.65591803 |
| 15 | MP0001819_abnormal_immune_cell | 2.60498761 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.44166731 |
| 17 | MP0002419_abnormal_innate_immunity | 2.39910396 |
| 18 | MP0002405_respiratory_system_inflammati | 2.36304775 |
| 19 | MP0000685_abnormal_immune_system | 2.29273883 |
| 20 | MP0010155_abnormal_intestine_physiology | 2.27556412 |
| 21 | MP0003436_decreased_susceptibility_to | 2.23239147 |
| 22 | MP0003866_abnormal_defecation | 2.22100026 |
| 23 | MP0003724_increased_susceptibility_to | 2.22078588 |
| 24 | MP0002398_abnormal_bone_marrow | 2.20880534 |
| 25 | MP0001873_stomach_inflammation | 2.16721903 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.15409373 |
| 27 | MP0000716_abnormal_immune_system | 2.10632427 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.95953436 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.91605504 |
| 30 | MP0005310_abnormal_salivary_gland | 1.90551778 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.90142285 |
| 32 | MP0002722_abnormal_immune_system | 1.83935573 |
| 33 | MP0003448_altered_tumor_morphology | 1.79079158 |
| 34 | MP0002429_abnormal_blood_cell | 1.67737270 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.66803372 |
| 36 | MP0001853_heart_inflammation | 1.57011015 |
| 37 | MP0002933_joint_inflammation | 1.56440251 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.52889569 |
| 39 | MP0004947_skin_inflammation | 1.51231627 |
| 40 | MP0008469_abnormal_protein_level | 1.44291600 |
| 41 | MP0003075_altered_response_to | 1.43619941 |
| 42 | MP0009764_decreased_sensitivity_to | 1.37784826 |
| 43 | MP0002877_abnormal_melanocyte_morpholog | 1.37134094 |
| 44 | MP0004381_abnormal_hair_follicle | 1.34122209 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.32615324 |
| 46 | MP0003045_fibrosis | 1.32459028 |
| 47 | MP0005377_hearing/vestibular/ear_phenot | 1.29555509 |
| 48 | MP0003878_abnormal_ear_physiology | 1.29555509 |
| 49 | MP0000858_altered_metastatic_potential | 1.28884372 |
| 50 | MP0002006_tumorigenesis | 1.27778424 |
| 51 | MP0002163_abnormal_gland_morphology | 1.26057448 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.19234857 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.18524252 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.14802047 |
| 55 | MP0009763_increased_sensitivity_to | 1.14126656 |
| 56 | MP0000343_altered_response_to | 1.07169687 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.07138180 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.05569936 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.05047892 |
| 60 | MP0004145_abnormal_muscle_electrophysio | 1.02389396 |
| 61 | MP0000015_abnormal_ear_pigmentation | 1.01396979 |
| 62 | MP0010307_abnormal_tumor_latency | 1.01380213 |
| 63 | MP0003303_peritoneal_inflammation | 1.01309106 |
| 64 | MP0005075_abnormal_melanosome_morpholog | 0.93900122 |
| 65 | MP0003183_abnormal_peptide_metabolism | 0.93539751 |
| 66 | MP0000920_abnormal_myelination | 0.90679592 |
| 67 | MP0003786_premature_aging | 0.88546222 |
| 68 | MP0005166_decreased_susceptibility_to | 0.85051622 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 0.82866838 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 0.82326997 |
| 71 | MP0008873_increased_physiological_sensi | 0.74516089 |
| 72 | MP0005379_endocrine/exocrine_gland_phen | 0.74448346 |
| 73 | MP0001661_extended_life_span | 0.69676153 |
| 74 | MP0001986_abnormal_taste_sensitivity | 0.66695690 |
| 75 | MP0003646_muscle_fatigue | 0.64745403 |
| 76 | MP0000249_abnormal_blood_vessel | 0.64054553 |
| 77 | MP0001188_hyperpigmentation | 0.63924556 |
| 78 | MP0002019_abnormal_tumor_incidence | 0.62823687 |
| 79 | MP0006035_abnormal_mitochondrial_morpho | 0.61524694 |
| 80 | MP0002693_abnormal_pancreas_physiology | 0.61142774 |
| 81 | MP0004883_abnormal_blood_vessel | 0.60959242 |
| 82 | MP0005083_abnormal_biliary_tract | 0.59001992 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 0.58395437 |
| 84 | MP0001905_abnormal_dopamine_level | 0.58325500 |
| 85 | MP0005058_abnormal_lysosome_morphology | 0.55241045 |
| 86 | MP0004130_abnormal_muscle_cell | 0.52953909 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.52885996 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 0.50672812 |
| 89 | MP0003011_delayed_dark_adaptation | 0.49797045 |
| 90 | MP0005165_increased_susceptibility_to | 0.49561970 |
| 91 | MP0004808_abnormal_hematopoietic_stem | 0.47955448 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 0.43675678 |
| 93 | MP0008004_abnormal_stomach_pH | 0.43652391 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 0.43121535 |
| 95 | MP0003690_abnormal_glial_cell | 0.42942831 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 0.42230551 |
| 97 | MP0004134_abnormal_chest_morphology | 0.41762156 |
| 98 | MP0003795_abnormal_bone_structure | 0.41244376 |
| 99 | MP0001765_abnormal_ion_homeostasis | 0.41217953 |
| 100 | MP0000609_abnormal_liver_physiology | 0.41217123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.08060022 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.01078332 |
| 3 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.63516784 |
| 4 | Abnormality of T cells (HP:0002843) | 4.70839201 |
| 5 | Optic neuritis (HP:0100653) | 4.65794793 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.65794793 |
| 7 | Myositis (HP:0100614) | 4.56778997 |
| 8 | Hypoproteinemia (HP:0003075) | 4.43657717 |
| 9 | Orchitis (HP:0100796) | 4.24250371 |
| 10 | Meningitis (HP:0001287) | 4.20977276 |
| 11 | Encephalitis (HP:0002383) | 4.14121368 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 4.11680622 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.11680622 |
| 14 | IgG deficiency (HP:0004315) | 4.11012483 |
| 15 | Increased IgM level (HP:0003496) | 4.09958846 |
| 16 | Hemoptysis (HP:0002105) | 4.08420312 |
| 17 | Autoimmune hemolytic anemia (HP:0001890) | 4.06863449 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.73832116 |
| 19 | Recurrent abscess formation (HP:0002722) | 3.71569472 |
| 20 | Abnormality of eosinophils (HP:0001879) | 3.70991126 |
| 21 | Obstructive lung disease (HP:0006536) | 3.68970088 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.68970088 |
| 23 | Pulmonary infiltrates (HP:0002113) | 3.67957584 |
| 24 | Severe combined immunodeficiency (HP:0004430) | 3.66556698 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.66488781 |
| 26 | Gangrene (HP:0100758) | 3.64160479 |
| 27 | Vasculitis (HP:0002633) | 3.61608816 |
| 28 | Recurrent fungal infections (HP:0002841) | 3.45863686 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.44953919 |
| 30 | Recurrent bronchitis (HP:0002837) | 3.42429280 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.35381625 |
| 32 | Panhypogammaglobulinemia (HP:0003139) | 3.34904594 |
| 33 | Chest pain (HP:0100749) | 3.33649274 |
| 34 | Abnormality of the prostate (HP:0008775) | 3.31203372 |
| 35 | Leukocytosis (HP:0001974) | 3.30454183 |
| 36 | Recurrent skin infections (HP:0001581) | 3.27594540 |
| 37 | Pulmonary embolism (HP:0002204) | 3.24115516 |
| 38 | Chronic diarrhea (HP:0002028) | 3.23521654 |
| 39 | Eosinophilia (HP:0001880) | 3.21828672 |
| 40 | Hemiplegia (HP:0002301) | 3.18674418 |
| 41 | Recurrent viral infections (HP:0004429) | 3.15746444 |
| 42 | Pustule (HP:0200039) | 3.10278805 |
| 43 | Keratoconjunctivitis (HP:0001096) | 3.08077748 |
| 44 | Stomatitis (HP:0010280) | 3.05811953 |
| 45 | Thyroiditis (HP:0100646) | 3.03459630 |
| 46 | Hypoplasia of the thymus (HP:0000778) | 3.03438208 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 3.01923132 |
| 48 | Combined immunodeficiency (HP:0005387) | 2.97749216 |
| 49 | Spontaneous hematomas (HP:0007420) | 2.95748984 |
| 50 | Abnormality of T cell physiology (HP:0011840) | 2.93698217 |
| 51 | 3-Methylglutaconic aciduria (HP:0003535) | 2.93654099 |
| 52 | Granulocytopenia (HP:0001913) | 2.93184252 |
| 53 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.88852420 |
| 54 | Abnormality of the pleura (HP:0002103) | 2.84947647 |
| 55 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.79938269 |
| 56 | Joint swelling (HP:0001386) | 2.74418888 |
| 57 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.74019903 |
| 58 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.74019903 |
| 59 | Lymphopenia (HP:0001888) | 2.71209822 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.70196326 |
| 61 | Agammaglobulinemia (HP:0004432) | 2.69794355 |
| 62 | Abnormal albumin level (HP:0012116) | 2.58937351 |
| 63 | Hypoalbuminemia (HP:0003073) | 2.58937351 |
| 64 | Arterial thrombosis (HP:0004420) | 2.56579233 |
| 65 | Amaurosis fugax (HP:0100576) | 2.49869562 |
| 66 | Ureteral stenosis (HP:0000071) | 2.47542813 |
| 67 | Epistaxis (HP:0000421) | 2.38756450 |
| 68 | Polyneuropathy (HP:0001271) | 2.37874138 |
| 69 | Eczematoid dermatitis (HP:0000976) | 2.37295357 |
| 70 | Abnormality of the pericardium (HP:0001697) | 2.37292860 |
| 71 | Zonular cataract (HP:0010920) | 2.33848537 |
| 72 | Glomerulopathy (HP:0100820) | 2.31844489 |
| 73 | Thrombophlebitis (HP:0004418) | 2.31013146 |
| 74 | Anorexia (HP:0002039) | 2.29620042 |
| 75 | Ureteral obstruction (HP:0006000) | 2.28776968 |
| 76 | Hematochezia (HP:0002573) | 2.17789760 |
| 77 | Lymphoma (HP:0002665) | 2.09131236 |
| 78 | Bronchitis (HP:0012387) | 2.03518582 |
| 79 | Recurrent otitis media (HP:0000403) | 2.02681388 |
| 80 | Acute hepatic failure (HP:0006554) | 2.00628530 |
| 81 | Stomach cancer (HP:0012126) | 2.00353824 |
| 82 | Gingival bleeding (HP:0000225) | 1.97887859 |
| 83 | Abnormality of glycolipid metabolism (HP:0010969) | 1.97797231 |
| 84 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.97797231 |
| 85 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.97797231 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.95689431 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 1.94483326 |
| 88 | Keratitis (HP:0000491) | 1.94007324 |
| 89 | Abnormality of male internal genitalia (HP:0000022) | 1.92773988 |
| 90 | Global brain atrophy (HP:0002283) | 1.90736904 |
| 91 | Pulmonary fibrosis (HP:0002206) | 1.88979988 |
| 92 | Urticaria (HP:0001025) | 1.88341064 |
| 93 | Gingivitis (HP:0000230) | 1.86824324 |
| 94 | Increased serum ferritin (HP:0003281) | 1.86639589 |
| 95 | Abnormal biliary tract physiology (HP:0012439) | 1.86314919 |
| 96 | Bile duct proliferation (HP:0001408) | 1.86314919 |
| 97 | Increased CSF protein (HP:0002922) | 1.83580948 |
| 98 | Tetraplegia (HP:0002445) | 1.82602102 |
| 99 | Cerebral ischemia (HP:0002637) | 1.82005253 |
| 100 | Purpura (HP:0000979) | 1.81638137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 9.83227009 |
| 2 | KDR | 3.33681072 |
| 3 | MAP4K1 | 3.11609590 |
| 4 | FES | 3.05428002 |
| 5 | GRK7 | 2.79070863 |
| 6 | RIPK4 | 2.50677411 |
| 7 | TRIM28 | 2.46155468 |
| 8 | JAK3 | 2.39595113 |
| 9 | ITK | 2.32512485 |
| 10 | CSK | 2.32450201 |
| 11 | TAOK3 | 2.01821999 |
| 12 | ZAP70 | 2.01142347 |
| 13 | PIK3CG | 1.96458774 |
| 14 | SYK | 1.95163271 |
| 15 | ADRBK2 | 1.94586968 |
| 16 | TGFBR2 | 1.87120328 |
| 17 | ZAK | 1.75931109 |
| 18 | LCK | 1.63447728 |
| 19 | BUB1 | 1.52885688 |
| 20 | BLK | 1.49890122 |
| 21 | IKBKE | 1.49641560 |
| 22 | MST4 | 1.46873917 |
| 23 | BTK | 1.44036223 |
| 24 | PRKCQ | 1.43433839 |
| 25 | JAK1 | 1.42633757 |
| 26 | MAP3K12 | 1.42289597 |
| 27 | TBK1 | 1.34639008 |
| 28 | LYN | 1.33844525 |
| 29 | BCKDK | 1.31192432 |
| 30 | MAP3K14 | 1.23893316 |
| 31 | TYRO3 | 1.19928149 |
| 32 | CSF1R | 1.18628374 |
| 33 | TEC | 1.17828493 |
| 34 | TESK2 | 1.16761785 |
| 35 | JAK2 | 1.12795417 |
| 36 | IRAK4 | 1.12450320 |
| 37 | PIK3CA | 0.97911640 |
| 38 | STK10 | 0.97569419 |
| 39 | TYK2 | 0.91537031 |
| 40 | FYN | 0.84564260 |
| 41 | MAPKAPK3 | 0.83999715 |
| 42 | IKBKB | 0.81136579 |
| 43 | MAP3K5 | 0.80049279 |
| 44 | DAPK1 | 0.79059956 |
| 45 | TNK2 | 0.77208539 |
| 46 | MAP2K6 | 0.77137868 |
| 47 | MELK | 0.77095165 |
| 48 | MYLK | 0.76912844 |
| 49 | FGR | 0.76540150 |
| 50 | PDK1 | 0.75673406 |
| 51 | STK16 | 0.73088670 |
| 52 | GRK6 | 0.69679498 |
| 53 | HCK | 0.66157230 |
| 54 | IRAK3 | 0.64733134 |
| 55 | BMPR2 | 0.63036473 |
| 56 | PIM1 | 0.61256539 |
| 57 | BCR | 0.61196228 |
| 58 | MATK | 0.57845600 |
| 59 | PDGFRB | 0.56427183 |
| 60 | FRK | 0.55342227 |
| 61 | IGF1R | 0.50101251 |
| 62 | MARK3 | 0.47893949 |
| 63 | KIT | 0.47760512 |
| 64 | NEK9 | 0.47583349 |
| 65 | MAPKAPK2 | 0.46296250 |
| 66 | MAPK7 | 0.42461559 |
| 67 | EIF2AK2 | 0.41557403 |
| 68 | NUAK1 | 0.39035455 |
| 69 | PDPK1 | 0.37985799 |
| 70 | INSR | 0.36466529 |
| 71 | ERN1 | 0.32749946 |
| 72 | ACVR1B | 0.32692099 |
| 73 | ADRBK1 | 0.31937852 |
| 74 | EPHB1 | 0.31852413 |
| 75 | HIPK2 | 0.28342003 |
| 76 | MOS | 0.26852782 |
| 77 | WNK4 | 0.26803828 |
| 78 | SIK3 | 0.26251982 |
| 79 | ABL1 | 0.25656272 |
| 80 | GRK5 | 0.25320386 |
| 81 | CAMKK2 | 0.23847815 |
| 82 | CLK1 | 0.22257939 |
| 83 | CHUK | 0.21239884 |
| 84 | GRK1 | 0.21076212 |
| 85 | MAP2K3 | 0.20991465 |
| 86 | MAPK3 | 0.19486399 |
| 87 | MAP3K3 | 0.18913099 |
| 88 | ROCK1 | 0.17638983 |
| 89 | MAP3K13 | 0.15526017 |
| 90 | MAPK11 | 0.14942944 |
| 91 | PRKCD | 0.14897600 |
| 92 | MAPK12 | 0.14829435 |
| 93 | LRRK2 | 0.14610789 |
| 94 | PRKCH | 0.14372836 |
| 95 | CDK6 | 0.13577870 |
| 96 | PRKCA | 0.12861539 |
| 97 | RET | 0.12386033 |
| 98 | IRAK1 | 0.11579471 |
| 99 | TIE1 | 0.10431359 |
| 100 | PAK1 | 0.08823784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.85614889 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.32949760 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.97551598 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.68146346 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.35138290 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.28297254 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.10522795 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.86872627 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.83920237 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.79582412 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.70775934 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.41033875 |
| 13 | Measles_Homo sapiens_hsa05162 | 2.22435489 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.20047370 |
| 15 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 2.11598110 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.08109989 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 2.01806853 |
| 18 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.90050193 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.88554279 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.84538245 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.83412724 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80186744 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.72510954 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.72509485 |
| 25 | Proteasome_Homo sapiens_hsa03050 | 1.59919464 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.54898163 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.52545798 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.46377179 |
| 29 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.34514515 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27790588 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25612964 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20265609 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.19414931 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17387301 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.11644362 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.03731120 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 0.96103578 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 0.94885494 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 0.90552192 |
| 40 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86752670 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.85041074 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 0.84481394 |
| 43 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83571766 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 0.78095036 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71836344 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67566459 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65886095 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 0.65665389 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61063209 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60783256 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58238325 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 0.57377971 |
| 53 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54396286 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.50031335 |
| 55 | Endocytosis_Homo sapiens_hsa04144 | 0.48630980 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45737004 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.41385767 |
| 58 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40854276 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36424421 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36129779 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.36093619 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35695304 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34092148 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.33971229 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32827245 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.32268149 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31587040 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.28146916 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25658710 |
| 70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25373257 |
| 71 | Parkinsons disease_Homo sapiens_hsa05012 | 0.24784321 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24379060 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24018918 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.21114072 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.18605018 |
| 76 | RNA polymerase_Homo sapiens_hsa03020 | 0.17110361 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.16070805 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.15656539 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.15160779 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.14977109 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.10178914 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.09354872 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.07431160 |
| 84 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.06468118 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.05415659 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.04965046 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.04118160 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.04108072 |
| 89 | Alzheimers disease_Homo sapiens_hsa05010 | 0.02286231 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.00703455 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.00663421 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.00581203 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0632543 |
| 94 | Complement and coagulation cascades_Homo sapiens_hsa04610 | -0.0629526 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | -0.0490082 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | -0.0485470 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | -0.0327712 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0228572 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0130666 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.0003659 |

